| Previous Close | 33.880 |
| Open | 33.950 |
| Bid | 34.220 x 10800 |
| Ask | 34.230 x 600 |
| Day's Range | 33.920 - 34.395 |
| 52 Week Range | 29.830 - 37.390 |
| Volume | 5,967,650 |
| Avg. Volume | 21,639,876 |
| Market Cap | 205.2B |
| Beta | 1.06 |
| PE Ratio (TTM) | 28.94 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Dividend & Yield | 1.28 (3.81%) |
| Ex-Dividend Date | 2017-05-10 |
| 1y Target Est | N/A |
- TheStreet.com•21 hours ago
Will Pfizer Reexamine a Sale of its Consumer Division?
Morgan Stanley analyst David Risinger argued for the drugmaker to part ways with its consumer health division.
- TheStreet.com•21 hours ago
Dems Roast Trump for Leaving Medicare Out of Drug Price Order
The main thrust of the order appears to be easing regulatory hurdles to drug approvals, which could lower the cost of bringing new treatments to market and thus lower prices.
- Barrons.com•22 hours ago
Pfizer: Time to Sell the Consumer Biz?
Back in November, reports circulated that Pfizer (PFE) was considering selling its consumer business. Then...nothing. Now Morgan Stanley analyst David Risinger and team are out with a note calling for ...
